Pasithea Therapeutics Corp.KTTA

$0.50-0.00 (-0.46%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$4M

Micro-cap

-90%

2021 — today

10-Year Price

-99%

2021 — today

52-Week Range

$0.29$1.47

Current $0.50· 18%

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.

Valuation in context

P/E ratio

-0.2

N/A

Not meaningful — company is unprofitable

P/B ratio

0.1

Near historic low

Near historic low — last 10 years

FCF Yield

-482.0%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when KTTA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.